SHARE YOUR
STORY

AMITIZA (lubiprostone) 24 mcg capsules twice daily is approved to treat Chronic Idiopathic Constipation (CIC) in adults. “Idiopathic” means the cause of the constipation is unknown and not due to an underlying illness or medication. AMITIZA 24 mcg twice daily is also approved to treat constipation caused by opioids, a type of prescription pain medicine, in adults with chronic, non-cancer pain. The effectiveness of AMITIZA has not been established if you are taking a diphenylheptane opioid (e.g., methadone). AMITIZA 8 mcg capsules twice daily is approved to treat Irritable Bowel Syndrome with Constipation (IBS-C) in women ≥18 years of age and older.

precallout section for AMITIZA. This needs update!

WHY SHARE
YOUR STORY?

We would like to give you the opportunity to share your personal treatment experiences. Participation is completely voluntary and you can choose to discontinue your participation in the program for any reason at any time.

WHAT COULD YOU
BE ASKED TO DO?

You may be invited to share your story in video, print, or web materials or participate in market research.

SHARE
YOUR STORY

Have you been diagnosed with Chronic Idiopathic Constipation (CIC), Irritable Bowel Syndrome with Constipation (IBS-C), or Opioid-Induced Constipation (OIC) with chronic, non-cancer pain and are taking AMITIZA? Consider sharing your story with us.

HOW TO SHARE
YOUR STORY

Thank you for your interest.

Please fill in the information requested and we will be in touch with you soon. Or, if you prefer, you can call us toll free at 1-888-740-0740.

All fields required.

 

Back to Top